BGI
AURA icon

B Group Inc’s Aura Biosciences AURA Stock Holding History

B Group Inc’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4M Buy
597,576
+25,000
+4% +$143K 2.96% 13
2025
Q4 		$3.12M Hold
572,576
– – 2.3% 12
2025
Q3 		$3.54M Hold
572,576
– – 2.6% 11
2025
Q2 		$3.58M Buy
572,576
+100,000
+21% +$585K 2.76% 10
2025
Q1 		$2.77M Hold
472,576
– – 2.37% 7
2024
Q4 		$3.88M Buy
+472,576
New +$4.45M 2.37% 8

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

B Group Inc's AURA Position: Q1 2026 in Review

B Group Inc increased its Aura Biosciences (AURA) stake by 4.4% in Q1 2026, buying an estimated $143K and bringing the position to 597,576 shares worth $4M. The position accounts for 2.96% of the portfolio, ranked #13.

B Group Inc first reported a position in AURA in Q4 2024 and has held it in 6 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • B Group Inc held 597,576 shares of Aura Biosciences worth $4M as of Q1 2026.
  • B Group Inc bought 25,000 Aura Biosciences shares in Q1 2026, an estimated $143K.
  • Aura Biosciences made up 2.96% of B Group Inc's portfolio in Q1 2026, its #13 holding.
  • B Group Inc first reported a position in Aura Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on B Group Inc's 13F filing for Q1 2026, filed 15 May 2026.